Release Date: 30/04/20 16:18 Summary: Quarterly Update and Appendix 4C Price Sensitive: Yes Download Document 369.66KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%